Skip to main
ADNT

Adient (ADNT) Stock Forecast & Price Target

Adient (ADNT) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 13%
Buy 13%
Hold 63%
Sell 13%
Strong Sell 0%

Bulls say

Adient, a prominent seating supplier within the automotive industry, reported fiscal 2025 consolidated revenue of $14.5 billion, excluding joint venture sales, indicating a robust market position. The company anticipates gaining further market share through onshored production initiatives and targeted gains from reshored programs, suggesting significant growth potential. Additionally, management expects to achieve margin expansion to a range of 5.0%-5.5% over the next two to three years, which could further enhance profitability and overall financial health.

Bears say

Adient continues to struggle with profitability due to inherited loss-making metals contracts and uncompetitive plants from before its spinoff, which have consistently impacted cash flow. Additionally, the company faces challenges in the EMEA region, characterized by lower vehicle production and an unfavorable production mix, further diminishing its revenue prospects. Geopolitical and macroeconomic uncertainties are expected to persist as headwinds to production in Europe, adding to the company’s financial difficulties.

Adient (ADNT) has been analyzed by 8 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 13% recommend Buy, 63% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Adient and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Adient (ADNT) Forecast

Analysts have given Adient (ADNT) a Hold based on their latest research and market trends.

According to 8 analysts, Adient (ADNT) has a Hold consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Adient (ADNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.